Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.10.5747

Golgi Phosphoprotein 2 Down-regulates the Th1 Response in Human Gastric Cancer Cells by Suppressing IL-12A  

Tang, Qing-Feng (Department of Clinical Laboratories & Experimental Center, Putuo Hospital, Shanghai University of Traditional Chinese Medicine)
Ji, Qing (Department of Clinical Laboratories & Experimental Center, Putuo Hospital, Shanghai University of Traditional Chinese Medicine)
Tang, Yu (Department of nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine)
Hu, Song-Jiao (Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine)
Bao, Yi-Jie (Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine)
Peng, Wen (Department of nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine)
Yin, Pei-Hao (Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.10, 2013 , pp. 5747-5751 More about this Journal
Abstract
Golgi phosphoprotein 2 (GOLPH2) is a very important biomarker in a variety of diseases. Its biological function is not clear, particularly in gastric cancer. To investigate the role of GOLPH2 in human gastric cancer, and determine its effect on the Th1 lymphocyte response, its expression and that of IL-12A were measured by real-time PCR and immunohistochemistry. The relationship between GOLPH2 and IL-12A was analysed statistically. The effect of GOLPH2 on the Th1 lymphocyte response was investigated with an in vitro co-culture system. The results showed that in human gastric cancer, the expression of GOLPH2 was significantly higher and the expression of IL-12A was lower than in normal gastric mucosal tissues, and the expression levels of GOLPH2 and IL-12A were negatively correlated. In addition, obvious down-regulation of the Th1 response was observed when lymphocytes were co-cultured with gastric cancer SGC7901 cells over-expressing GOLPH2. GOLPH2 down-regulated the expression of IL-12A, and inhibited the expression of TNF-${\alpha}$ and IFN-${\gamma}$. The results indicated that GOLPH2 down-regulates the Th1 response via suppression of IL-12A in human gastric cancer, and this might provide a target for the prevention and treatment.
Keywords
Golgi phosphoprotein 2; Th1 response; human gastric cancer; IL-12A;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Fritzsche FR, Riener MO, Dietel M, et al (2008). GOLPH2 expression in renal cell cancer. BMC Urol, 8, 15.   DOI   ScienceOn
2 Airoldi I, Guglielmino R, Carra G, et al (2002). The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes. Haematologica, 87, 434-42.
3 Boes M, Prodeus AP, Schmidt T, et al (1998). A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med, 188, 2381-6.   DOI
4 Clark IA (2007). How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev, 18, 335-43.   DOI   ScienceOn
5 Correa P (2013). Gastric cancer: overview. Gastroenterol Clin North Am, 42, 211-7.   DOI
6 Fritzsche FR, Kristiansen G, Riener MO, et al (2010). GOLPH2 expression may serve as diagnostic marker in seminomas. BMC Urol, 10, 4.   DOI   ScienceOn
7 Gong Y, Long Q, Xie H, et al (2012). Cloning and characterization of human Golgi phosphoprotein 2 gene (GOLPH2/GP73/GOLM1) promoter. Biochem Biophys Res Commun, 421, 713-20.   DOI   ScienceOn
8 Gray PW, Goeddel DV (1982). Structure of the human immune interferon gene. Nature, 298, 859-63.   DOI   ScienceOn
9 Hu L, Li L, Xie H, et al (2011).The Golgi localization of GOLPH2 (GP73/GOLM1) is determined by the transmembrane and cytoplamic sequences. PLoS One, 6, e28207.   DOI
10 Kim HJ, Lv D, Zhang Y, et al (2012). Golgi phosphoprotein 2 in physiology and in diseases. Cell Biosci, 2, 31.   DOI   ScienceOn
11 Kim JJ (2013). Upper gastrointestinal cancer and reflux disease. J Gastric Cancer, 13, 79-85.   과학기술학회마을   DOI   ScienceOn
12 Kristiansen G, Fritzsche FR, Wassermann K, et al (2008). GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer, 99, 939-48.   DOI   ScienceOn
13 Laxman B, Morris DS, Yu J, et al (2008). A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res, 68, 645-9.   DOI   ScienceOn
14 Old LJ (1985). Tumor necrosis factor (TNF). Science, 230, 630-2.   DOI
15 Peluso I, Pallone F, Monteleone G (2006). Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol, 12, 5606-10.
16 Reid RR, Prodeus AP, Khan W, et al (1997). Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol, 159, 970-5.
17 Riener MO, Stenner F, Liewen H, et al (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49, 1602-9.   DOI   ScienceOn
18 Rival YA. Maschio D, Rabiet MJ, et al (1996). Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-${\alpha}$ and IFN-${\gamma}$. J Immunol, 157, 1233.
19 Said EA, Dupuy FP, Trautmann L, et al (2010). Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nature Med, 16, 452-9.   DOI   ScienceOn
20 Roobol MJ, Haese A, Bjartell A (2011).Tumour markers in prostate cancer III: biomarkers in urine. Acta Oncol, 50 (Suppl 1), 85-9.   DOI   ScienceOn
21 Wajant H, Pfizenmaier K, Scheurich P (2003). Tumor necrosis factor signaling. Cell Death Differ, 10, 45-65.   DOI   ScienceOn
22 Schoenborn JR, Wilson CB (2007). Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol, 96, 41-101.   DOI   ScienceOn
23 Schroder K, Hertzog PJ, Ravasi T, et al (2004). Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol, 75, 163-89.
24 Wang L, Zhao YH, Liu Y, et al (2013). IFN-${\gamma}$ and TNF-${\alpha}$ synergistically induce mesenchymal stem cell impairment and tumorigenesis via $NF{\kappa}B$ signaling. Stem Cells, 31, 1383-95.   DOI
25 Wei S, Dunn TA, Isaacs WB, et al (2008). GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus. Prostate, 68, 1387-95.   DOI   ScienceOn
26 Wolf SF, Temple PA, Kobayashi M, et al (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol, 146, 3074-81.
27 Zhang F, Gu Y, Li X, et al (2010). Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue. Clin Biochem, 43, 983-91.   DOI   ScienceOn
28 Sugano K (2013). Premalignant conditions of gastric cancer. J Gastroenterol Hepatol, 28, 906-11.   DOI   ScienceOn
29 Romer LH, McLean NV, Yan HC, et al (1995). IFN-${\gamma}$ and TNF-${\alpha}induce$ redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol, 154, 6582.
30 Pietrantonio F, De Braud F, Da Prat V, et al (2013). A review on biomarkers for prediction of treatment outcome in gastric cancer. Anticancer Res, 33, 1257-66.